PAIN
MANAGEMENT
Prepare by
Halimatu Usman RN, BSN
2
Introduction
 Definition : An unpleasant sensory and
emotional experience associated with
actual or potential tissue damage.
 Pain may not be directly proportional to
amount of tissue injury.
 Highly subjective, leading to
undertreatment
3
 In cancer, the prevalence of pain in
advanced disease is 70-90%.
 " In HIV disease, pain prevalence is
about 50%.
 " Other illnesses may have significant
pain but no clear data.
4
Classification
I. Acute
II. Chronic :
i. Non malignant
ii. Malignant
5
 Injury, trauma, spasm or disease to skin, muscle, somatic
structures or viscera;
 Perceived and communicated via peripheral mechanisms
(pathways)
 Usually associated with autonomic response as well
(tachycardia, blood pressure, diaphoresis, pallor,
mydriasis (pupil dilation).
I. Acute Pain
6
i. Non-malignant
 Pain persists beyond the precipitating injury
 Rarely accompanied by autonomic symptoms
 Sufferers often fail to demonstrate objective
evidence of underlying pathology.
 Characterized by location-visceral, myofacial, or
neurologic causes.
II. Chronic Pain
7
ii. Malignant
 Has characteristics of chronic pain as well as
symptoms of acute pain (breakthrough pain).
 Has a definable cause, e.g. tumor recurrence
 In treatment, narcotic habituation is generally
not a concern.
II. Chronic Pain
8
 Types of Pain
 Somatic
 Visceral
 Bone
 Neuropathic
 Emotional/Spiritual
9
I- Somatic Pain
 Aching, often constant
 May be dull or sharp
 Often worse with movement
 Well localized
 Skin, Muscle, Joints, superficial or deep.
 Eg:
o Bone & soft tissue
o chest wall
10
II- Visceral Pain
 Constant or crampy
 Aching, burning
 Poorly localized
 Referred
 Organs of Thorax & Abdominal Cavity.
 Usually as a result of stretching, infiltration and
compression
 Eg:
o Liver capsule distension
o Bowel obstruction
11
III- Bone Pain
 Poorly localized, aching, deep, burning.
 Common with malignancy of Breast, Lung,
Prostate, Bladder, Cervical, Renal, Colon,
Stomach and Esophagus
 Can lead to pathological fractures.
 Vertebral Metastases can lead to cord
compression.
12
IV- Neuropathic Pain
 Caused by disturbance of function or pathological
changes in a nerve.
 May arise from a lesion or trauma, infection,
compression or tumour invasion.
 Described as burning, shooting, tingling.
 Does not respond well to standard analgesics.
13
 Categories of Pain
 Classified by inferred pathophysiology:
I. Nociceptive pain (stimuli from somatic and
visceral structures)
II. Neuropathic pain (stimuli abnormally
processed by the nervous system)
14
I. Nociceptive:
 Caused by invasion &/or destruction &/or pressure on
superficial somatic structures like skin, deeper skeletal
structures such as bone & muscle and visceral structures
and organs.
 Types: superficial somatic, deep somatic, & visceral.
15
II. Neuropathic:
 Caused by pressure on &/or destruction of peripheral,
autonomic or central nervous system structures.
 Radiation of pain along dermatomal or peripheral nerve
distributions.
 Often described as burning and/or deep aching &
associated with dysesthesia or lancinating pain.
16
Effects of pain
 Sympathetic responses
o Pallor
o Increased blood pressure
o Increased pulse
o Increased respiration
o Skeletal muscle tension
o Diaphoresis
17
Effects of pain
 Parasympathetic responses
o Decreased blood pressure
o Decreased pulse
o Nausea & vomiting
o Weakness
o Pallor
o Loss of consciousness
18
Pain History
 The site of pain
 Type of pain
 Exacerbating & Relieving factors
 How frequently
 Impact on daily life
19
Pain History
 Other important additional questions to be asked.
o What is the response to past and current analgesic
therapy?
o Any kind of diary or record about the pain?
o Fears they have about analgesics?
20
PAIN ASSESSMENT Tools
Verbal Analogue Scales.
Visual Analogue Scales.
The Faces Scale
21
Factors to consider in choosing a
pain scale
1. Age of patient
2. Physical condition
3. Level of consciousness
4. Mental status
5. Ability to communicate
22
Numeric Pain Rating Scale
 Ask the patient to rate their pain intensity on a scale of 0 (no pain) to 10
(the worst pain imaginable).
 Some patients are unable to do this with only verbal instructions, but may
be able to look at a number scale and point to the number that describes
the intensity of pain.
23
Wong-Baker FACES Pain Rating Scale
 Can be used with young children (sometimes as young as 3 years of age)
 Works well for many older children and adults as well as for those who speak a
different language
 Explain that each face represents a person who may have no pain, some pain, or as
much pain as imaginable. Point to the appropriate face and say the appropriate
description. e.g. “This face hurts just a little bit”
 Ask the patient to choose the face that best matches how she or he feels or how much
they hurt.
24
Severity Assessment
 McGill Pain Questionnaire
 Scale from 0 to 5
 From None to Severe Pain
 for children or adults who understand numerical
relationships.
25
Goals of Pain Management Therapy
1) Decreased pain
2) Decreased healthcare utilization
o Decreased “shopping” for care
o Decreased emergency room visits
3) Improved functional status
o Increased ability to perform activities of daily living
o Return to employment
26
Management
 Non-Pharamcological treatment
 Pharmacological treatment:
 Analgesics
 Adjuvants
 Others
27
Non-pharmacological interventions
 Exercise
 Weight reduction
 Counseling
 Smoking cessation
 Massage ,Relaxation therapy
 Heat & cold applications
28
WHO Pain Management Ladder
 Step I:
 NSAIDS ± adjuvants
 Step II:
 NSAID + Mild opioids ± adjuvant
 Step III:
 Strong opioids + NSAIDS ± adjuvants
29
Opioid Dosing
 Opioid analgesia is most effective when titrated to effect.
 Effective doses are highly variable between patients.
 “Standard” doses may be insufficient.
 When used properly for analgesia addiction occurs in less
than 1% of patients.
30
Opioid Side Effects
 Constipation :
o need proactive laxative use
 Nausea/vomiting:
o consider treating with dopamine antagonists and/or prokinetics (metoclopramide, domperidone,
prochlorperazine, haloperidol)
 Urinary retention
 Itch/rash
o worse in children; may need low-dose naloxone infusion. May try antihistamines, however not great
success
 Dry mouth
 Respiratory depression
o uncommon when titrated in response to symptom
ThanKs You
for Listining

Pain Management Slides By Halimatu Usman.pdf

  • 1.
  • 2.
    2 Introduction  Definition :An unpleasant sensory and emotional experience associated with actual or potential tissue damage.  Pain may not be directly proportional to amount of tissue injury.  Highly subjective, leading to undertreatment
  • 3.
    3  In cancer,the prevalence of pain in advanced disease is 70-90%.  " In HIV disease, pain prevalence is about 50%.  " Other illnesses may have significant pain but no clear data.
  • 4.
    4 Classification I. Acute II. Chronic: i. Non malignant ii. Malignant
  • 5.
    5  Injury, trauma,spasm or disease to skin, muscle, somatic structures or viscera;  Perceived and communicated via peripheral mechanisms (pathways)  Usually associated with autonomic response as well (tachycardia, blood pressure, diaphoresis, pallor, mydriasis (pupil dilation). I. Acute Pain
  • 6.
    6 i. Non-malignant  Painpersists beyond the precipitating injury  Rarely accompanied by autonomic symptoms  Sufferers often fail to demonstrate objective evidence of underlying pathology.  Characterized by location-visceral, myofacial, or neurologic causes. II. Chronic Pain
  • 7.
    7 ii. Malignant  Hascharacteristics of chronic pain as well as symptoms of acute pain (breakthrough pain).  Has a definable cause, e.g. tumor recurrence  In treatment, narcotic habituation is generally not a concern. II. Chronic Pain
  • 8.
    8  Types ofPain  Somatic  Visceral  Bone  Neuropathic  Emotional/Spiritual
  • 9.
    9 I- Somatic Pain Aching, often constant  May be dull or sharp  Often worse with movement  Well localized  Skin, Muscle, Joints, superficial or deep.  Eg: o Bone & soft tissue o chest wall
  • 10.
    10 II- Visceral Pain Constant or crampy  Aching, burning  Poorly localized  Referred  Organs of Thorax & Abdominal Cavity.  Usually as a result of stretching, infiltration and compression  Eg: o Liver capsule distension o Bowel obstruction
  • 11.
    11 III- Bone Pain Poorly localized, aching, deep, burning.  Common with malignancy of Breast, Lung, Prostate, Bladder, Cervical, Renal, Colon, Stomach and Esophagus  Can lead to pathological fractures.  Vertebral Metastases can lead to cord compression.
  • 12.
    12 IV- Neuropathic Pain Caused by disturbance of function or pathological changes in a nerve.  May arise from a lesion or trauma, infection, compression or tumour invasion.  Described as burning, shooting, tingling.  Does not respond well to standard analgesics.
  • 13.
    13  Categories ofPain  Classified by inferred pathophysiology: I. Nociceptive pain (stimuli from somatic and visceral structures) II. Neuropathic pain (stimuli abnormally processed by the nervous system)
  • 14.
    14 I. Nociceptive:  Causedby invasion &/or destruction &/or pressure on superficial somatic structures like skin, deeper skeletal structures such as bone & muscle and visceral structures and organs.  Types: superficial somatic, deep somatic, & visceral.
  • 15.
    15 II. Neuropathic:  Causedby pressure on &/or destruction of peripheral, autonomic or central nervous system structures.  Radiation of pain along dermatomal or peripheral nerve distributions.  Often described as burning and/or deep aching & associated with dysesthesia or lancinating pain.
  • 16.
    16 Effects of pain Sympathetic responses o Pallor o Increased blood pressure o Increased pulse o Increased respiration o Skeletal muscle tension o Diaphoresis
  • 17.
    17 Effects of pain Parasympathetic responses o Decreased blood pressure o Decreased pulse o Nausea & vomiting o Weakness o Pallor o Loss of consciousness
  • 18.
    18 Pain History  Thesite of pain  Type of pain  Exacerbating & Relieving factors  How frequently  Impact on daily life
  • 19.
    19 Pain History  Otherimportant additional questions to be asked. o What is the response to past and current analgesic therapy? o Any kind of diary or record about the pain? o Fears they have about analgesics?
  • 20.
    20 PAIN ASSESSMENT Tools VerbalAnalogue Scales. Visual Analogue Scales. The Faces Scale
  • 21.
    21 Factors to considerin choosing a pain scale 1. Age of patient 2. Physical condition 3. Level of consciousness 4. Mental status 5. Ability to communicate
  • 22.
    22 Numeric Pain RatingScale  Ask the patient to rate their pain intensity on a scale of 0 (no pain) to 10 (the worst pain imaginable).  Some patients are unable to do this with only verbal instructions, but may be able to look at a number scale and point to the number that describes the intensity of pain.
  • 23.
    23 Wong-Baker FACES PainRating Scale  Can be used with young children (sometimes as young as 3 years of age)  Works well for many older children and adults as well as for those who speak a different language  Explain that each face represents a person who may have no pain, some pain, or as much pain as imaginable. Point to the appropriate face and say the appropriate description. e.g. “This face hurts just a little bit”  Ask the patient to choose the face that best matches how she or he feels or how much they hurt.
  • 24.
    24 Severity Assessment  McGillPain Questionnaire  Scale from 0 to 5  From None to Severe Pain  for children or adults who understand numerical relationships.
  • 25.
    25 Goals of PainManagement Therapy 1) Decreased pain 2) Decreased healthcare utilization o Decreased “shopping” for care o Decreased emergency room visits 3) Improved functional status o Increased ability to perform activities of daily living o Return to employment
  • 26.
    26 Management  Non-Pharamcological treatment Pharmacological treatment:  Analgesics  Adjuvants  Others
  • 27.
    27 Non-pharmacological interventions  Exercise Weight reduction  Counseling  Smoking cessation  Massage ,Relaxation therapy  Heat & cold applications
  • 28.
    28 WHO Pain ManagementLadder  Step I:  NSAIDS ± adjuvants  Step II:  NSAID + Mild opioids ± adjuvant  Step III:  Strong opioids + NSAIDS ± adjuvants
  • 29.
    29 Opioid Dosing  Opioidanalgesia is most effective when titrated to effect.  Effective doses are highly variable between patients.  “Standard” doses may be insufficient.  When used properly for analgesia addiction occurs in less than 1% of patients.
  • 30.
    30 Opioid Side Effects Constipation : o need proactive laxative use  Nausea/vomiting: o consider treating with dopamine antagonists and/or prokinetics (metoclopramide, domperidone, prochlorperazine, haloperidol)  Urinary retention  Itch/rash o worse in children; may need low-dose naloxone infusion. May try antihistamines, however not great success  Dry mouth  Respiratory depression o uncommon when titrated in response to symptom
  • 31.